GLP-3R 10MG

GLP-3R is an experimental, structurally modified 39-amino-acid peptide engineered for profound metabolic and homeostatic research. Representing the cutting edge of metabolic science, GLP-3R functions as a first-in-class single-peptide “triple agonist,” simultaneously targeting three key metabolic receptor pathways: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and GCGR (glucagon receptor).

In contemporary laboratory research, this novel compound is heavily investigated for its synergistic impact on energy expenditure, adipose tissue lipolysis (the breakdown of stored fat), and glycemic control. By integrating glucagon receptor activation alongside traditional incretin pathways, GLP-3R allows researchers to explore enhanced metabolic rate dynamics and therapeutic avenues for severe metabolic dysfunction and obesity models.

Core Research Areas

• Triple-Receptor Synergy: Simultaneously activates GIP, GLP-1, and Glucagon pathways to explore multi-lane metabolic regulation.

• Adipose Tissue Metamorphosis: Researched for its direct impact on accelerating lipid clearance and elevating base energy expenditure via glucagon pathways.

• Glycemic Control Models: Investigated for glucose-dependent insulin secretion pathways and homeostatic stability under metabolic duress.

Storage & Handling

• Lyophilized: Stable at room temp for up to 3 weeks. Store long-term desiccated below -18°C.

Laboratory Research Disclaimer: This product is synthesized and distributed exclusively for laboratory research use and in vitro testing. It is not approved for human consumption, therapeutic use, or clinical application.